Group 1: Company Overview and Event Details - The investor relations activity was conducted as a live performance, showcasing the subsidiary Boling Brain Machine's introduction video and product demonstrations [2] - The event took place on September 25, 2025, at the Innovation Medical Hangzhou branch [2] Group 2: Product Features and Clinical Testing - Boling Brain Machine products are designed to be lightweight, user-friendly, and simple to operate, utilizing brain-machine interface technology to enhance patient rehabilitation [3] - Over 100 patients have participated in multi-center clinical tests, showing significant improvements in Fugl-Meyer scores for both newly diagnosed and long-term stroke patients [3][4] Group 3: Product Specifications and Future Developments - The C-end product weighs 1.5 kg and has a battery life of approximately 6 hours per battery, with two batteries included [3] - Future products include a dexterous hand for fine motor control and a pneumatic glove for gross motor actions, with ongoing research into invasive technology [4] Group 4: Economic Impact and Cost Savings - The C-end product can save families between 40,000 to 60,000 CNY annually by reducing the need for full-time caregivers [6] - Traditional rehabilitation costs can reach 65,000 CNY per year, while the Boling Brain Machine allows for home-based training, significantly lowering expenses [6] Group 5: Company Ownership and Market Position - The company holds a 68.356% stake in Boling Brain Machine, which is included in the consolidated financial statements [6]